- Home
- MRVI vs RCKT Comparison
MRVI vs RCKT Comparison
Compare MRVI & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRVI
- RCKT
- Stock Information
- Founded
- MRVI 2020
- RCKT 1999
- Country
- MRVI United States
- RCKT United States
- Employees
- MRVI N/A
- RCKT N/A
- Industry
- MRVI Biotechnology: Pharmaceutical Preparations
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- MRVI Health Care
- RCKT Health Care
- Exchange
- MRVI Nasdaq
- RCKT Nasdaq
- Market Cap
- MRVI 1.2B
- RCKT 1.4B
- IPO Year
- MRVI 2020
- RCKT N/A
- Fundamental
- Price
- MRVI $4.42
- RCKT $13.98
- Analyst Decision
- MRVI Buy
- RCKT Strong Buy
- Analyst Count
- MRVI 11
- RCKT 9
- Target Price
- MRVI $10.33
- RCKT $53.22
- AVG Volume (30 Days)
- MRVI 2.5M
- RCKT 744.0K
- Earning Date
- MRVI 11-07-2024
- RCKT 11-07-2024
- Dividend Yield
- MRVI N/A
- RCKT N/A
- EPS Growth
- MRVI N/A
- RCKT N/A
- EPS
- MRVI N/A
- RCKT N/A
- Revenue
- MRVI $276,920,000.00
- RCKT N/A
- Revenue This Year
- MRVI N/A
- RCKT N/A
- Revenue Next Year
- MRVI $7.10
- RCKT $411.05
- P/E Ratio
- MRVI N/A
- RCKT N/A
- Revenue Growth
- MRVI N/A
- RCKT N/A
- 52 Week Low
- MRVI $4.39
- RCKT $13.80
- 52 Week High
- MRVI $11.56
- RCKT $32.53
- Technical
- Relative Strength Index (RSI)
- MRVI 26.26
- RCKT 27.71
- Support Level
- MRVI $4.71
- RCKT $16.65
- Resistance Level
- MRVI $6.34
- RCKT $17.83
- Average True Range (ATR)
- MRVI 0.49
- RCKT 0.89
- MACD
- MRVI -0.27
- RCKT -0.27
- Stochastic Oscillator
- MRVI 0.77
- RCKT 4.12
About MRVI Maravai LifeSciences Holdings Inc.
Maravai LifeSciences Holdings Inc is a life sciences company. It provides products to enable the development of drug therapies, diagnostics, and novel vaccines and supports research on human diseases. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis.